The Impact of Implementing a Universal Newborn Screening for Critical Congenital Heart Disease
| Status: | Active, not recruiting |
|---|---|
| Conditions: | Peripheral Vascular Disease, Cardiology |
| Therapuetic Areas: | Cardiology / Vascular Diseases |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 7/30/2016 |
| Start Date: | June 2012 |
| End Date: | December 2016 |
The purpose of this study is to evaluate the impact of implementing a universal pulse
oximeter screening as a way to detect critical congenital heart disease in otherwise
well-appearing newborns.
oximeter screening as a way to detect critical congenital heart disease in otherwise
well-appearing newborns.
Inclusion Criteria:
1. Documentation of informed consent and authorization.
2. Full term and late preterm newborns (EGA 35-44 weeks)
3. On room air
4. Neonates known to have a congenital heart defect at the time of screening, e.g.,
antenatal diagnosis or diagnosis within the first 24 hours after birth
5. Parents agree to follow-up contact post discharge
Exclusion Criteria:
1. On supplemental oxygen
2. Admitted to the Neonatal Intensive Care Unit
3. Parents do not agree to follow-up
4. Greater than 30 days of age
We found this trial at
1
site
Click here to add this to my saved trials
